Home › Supplement Vault › Feverfew

Feverfew

Cognitive & Mood✅ Clinically validated📊 Correlative data🧪 Theoretical

A migraine herb sold on a marker molecule that may not be the active one. Labels standardize to parthenolide, a sesquiterpene lactone; a controlled trial of an alcoholic extract standardized to parthenolide failed, while the extract with the best trial result is a supercritical CO2 preparation with a different constituent profile. That is an awkward fact for a category whose entire quality claim is the parthenolide number.

Educational use only — not medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

Feverfew quick facts

Suggested doseDried leaf products run 100–380 mg daily; extracts state a parthenolide percentage, commonly 0.2–0.7%. Prophylaxis is judged over months, not days.
How oftenDaily, as prophylaxis rather than for an attack in progress
Who it's forPeople with frequent migraine looking at herbal prophylaxis, who will note down attack frequency before starting.
Coach Cam’s take

Buy by extract type rather than by parthenolide percentage, and set the expectation to months — migraine prophylaxis is judged on attack frequency over a season, so write down the baseline before starting or there is nothing to compare against. Do not chew the raw leaf; mouth ulceration is the classic dose-related adverse effect. Stop gradually rather than abruptly, because a rebound of headache, anxiety and joint stiffness after long use is described. Anyone on an anticoagulant or antiplatelet, anyone with ragweed or daisy allergy, and anyone pregnant should leave this one alone.

How Feverfew actually works

Parthenolide, the sesquiterpene lactone the labels standardize to, carries an alpha-methylene-gamma-lactone that acts as a Michael acceptor: it alkylates cysteine residues, including Cys179 of IKK-beta, which blocks NF-kappa-B activation, and it also agonizes TRPA1 on sensory neurons, where prolonged activation defunctionalizes the terminal. Both are real chemistry. What the standardization does not capture is that feverfew leaf contains a large family of other sesquiterpene lactones and flavonoids whose proportions vary with chemotype, plant part and growing region, and that the extract with the best controlled result is a supercritical carbon dioxide preparation with a profile unlike an alcoholic extract of the same parthenolide content. The marker molecule and the active principle may not be the same thing, which is an uncomfortable position for a category that sells itself on a percentage.

⚠️ Good to know: Buy by extract type, not by parthenolide percentage. The percentage tells you what one molecule is doing in the bottle, and the trial that worked best was not run on that molecule alone.
⏱ Timing that matters for safety: Taper rather than stop - abrupt discontinuation after long-term use has a described rebound of headache, anxiety and joint stiffness - and stop it two weeks before surgery on the coagulation grounds

Where to get Feverfew

Find Feverfew on iHerb →
Top-rated brands on iHerb · Coach Cam partner link

The evidence for Feverfew

Graded by what exists behind each claim.

✅ Clinically validated

📊 Correlative data

🧪 Theoretical / extrapolated benefits

How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →

What Feverfew actually does

Parthenolide is a Michael acceptor, and that single chemical fact explains both its pharmacology and its side effects. It is a germacranolide sesquiterpene lactone carrying an alpha-methylene-gamma-lactone, an electron-poor alkene that reacts covalently with nucleophilic thiols. In cells the target that matters is Cys179 of IKK-beta: alkylating it blocks phosphorylation of I-kappa-B, so NF-kappa-B is never released to the nucleus and the inflammatory transcriptional program does not start.

The same reactivity gives it a second target on the neurons that matter for headache. Parthenolide activates TRPA1 on trigeminal sensory terminals, and prolonged activation defunctionalizes the terminal, reducing subsequent CGRP release — an agonist that works by exhausting the channel rather than blocking it Kaur 2021. It is the same logic as topical capsaicin, and it predicts an initial irritant phase, which is precisely what chewing the leaf produces.

And the same reactivity is why it alkylates the mucosa of anybody who chews the raw leaf. Mouth ulceration and tongue swelling are not an allergy in most cases; they are a Michael acceptor meeting the thiols in oral epithelium.

Here is the uncomfortable part, and it belongs in the mechanism section rather than buried. Feverfew leaf contains a large family of sesquiterpene lactones and flavonoids whose proportions vary with chemotype, plant part and growing region Giuliani 2024, and the extract with the best controlled migraine result is a supercritical carbon dioxide preparation whose profile is not that of an alcoholic extract of matched parthenolide content. A controlled trial of an alcoholic extract standardized to parthenolide did not beat placebo. The marker molecule and the active principle may not be the same thing.

That is a structural problem for a category whose entire quality claim is a percentage. Standardizing to parthenolide guarantees consistency of one constituent and says nothing about the rest of the profile, which is where the difference between the extracts that worked and the ones that did not appears to live.

Cell, rodent, human — and where it stops

In the plant. Phytochemical characterization of Tanacetum species shows parthenolide as one member of a broad sesquiterpene lactone and flavonoid profile that shifts with species, plant part and region Giuliani 2024. That is the analytical basis for saying two feverfew products are not the same material.

In commerce, which is a step most botanicals skip and this one cannot. A review of chemical authentication of commercial herbal products documents identity and content failures across the botanical supplement market Ichim 2021. For a plant whose active principle is uncertain and whose marker varies with chemotype, that is not a background concern — it is the main source of variance between two bottles.

In people, the reviews are split along extract lines. Nutraceutical migraine prophylaxis reviews place feverfew in the tier where some preparations have positive controlled data and others do not, with extract type rather than dose explaining much of the disagreement Kaur 2021. Reviews of herbal pain management reach the same conclusion and add the interaction profile Jahromi 2021.

The specific obstacle to transfer, stated once. A reader buying a 380 mg dried-leaf capsule is not buying the material that produced the positive trials, and no label gives them a way to tell. The percentage on the front is a measurement of the one molecule whose primacy is in doubt.

Feverfew — which form, and does it matter

Buy by extract type, not by parthenolide percentage. That is the whole form argument and it inverts what the category teaches.

Three preparations are sold. Dried leaf, 100 to 380 mg daily, which is the traditional material and the one with the weakest trial record. Alcoholic extracts standardized to a parthenolide percentage, usually 0.2 to 0.7 percent. And supercritical carbon dioxide extracts, which carry a different constituent profile because CO2 extracts lipophilic compounds and leaves polar ones behind — the same separation principle that makes CO2 extraction useful for butterbur.

Parthenolide is also chemically unstable in storage. It degrades with heat, light and time, so a bottle's stated percentage is a manufacturing figure rather than a shelf figure, and authentication work finds exactly this class of discrepancy across commercial herbal products Ichim 2021.

Exposure arithmetic, and it is small. A 380 mg leaf capsule at 0.2 percent parthenolide delivers 0.76 mg. At 0.7 percent it delivers 2.7 mg. That is a three-and-a-half-fold range across products that look identical on a shelf, and it sits underneath a plasma half-life short enough that daily dosing is about maintaining a transcriptional effect rather than a concentration.

Timescale is set by the indication. This is prophylaxis. The endpoint is migraine days per month and it is judged over three to four months Kaur 2021, which means the baseline has to be written down before the first capsule or there is nothing to compare against.

What would have to be true, and how you would know it was not

The efficacy prediction is a headache diary with a real baseline. Migraine days per month for 4 weeks before starting, then monthly for 12 weeks. Migraine frequency regresses to the mean powerfully, and people start prophylaxis after a bad month, so a baseline collected retrospectively will always flatter the supplement.

The prediction that tests the mechanism. If the TRPA1 defunctionalization account is right, there should be an early phase of increased rather than decreased sensory irritation — the capsaicin pattern — before any prophylactic benefit appears Kaur 2021. A product that produces nothing at all in week one and a large effect in week two fits the transcriptional account better than the channel one.

The safety prediction, and it is a laboratory one. A case report documents altered coagulation test results with feverfew Alenzi 2021. In anyone on an anticoagulant, INR should be checked within two weeks of starting and again after stopping — this is a herb whose most concrete published adverse effect is a number on a clotting screen, and checking it is cheap.

The prediction that cuts against the category. If parthenolide were the active principle, then two products matched on parthenolide content should perform identically. The trial record suggests they do not Kaur 2021, and anyone who finds a dried-leaf product and a CO2 extract equivalent at matched parthenolide has falsified this page's central claim.

What nobody has tested yet

Nobody knows what the active principle is. That is a remarkable thing to be able to say about a herb in continuous commercial use, and it is the honest state of the field: parthenolide is the marker, the alcoholic extract standardized to it failed, and the constituent profile that differs between the extracts that worked and those that did not has never been characterized well enough to name a replacement Giuliani 2024.

No trial has compared preparations head to head. Dried leaf against alcoholic extract against CO2 extract, matched on parthenolide, with migraine days as the endpoint, would answer the question the whole category is built on. It has not been run.

The post-feverfew syndrome has never been characterized prospectively. Rebound headache, anxiety and joint stiffness after abrupt discontinuation of long-term use is described in the clinical literature and in review Jahromi 2021, but its incidence, time course and dose-dependence are unmeasured, so nobody can say how slowly to taper.

Feverfew — its own safety story, not its category's

Feverfew's own risks are not the generic herb risks, and two of them are unusual.

Coagulation. A case report documents altered coagulation test results and vaginal bleeding attributed to feverfew Alenzi 2021. Treat it as additive with anticoagulants, antiplatelets and aspirin, and stop it well before surgery or dental extraction — surgeons ask about prescription blood thinners and rarely about herbs.

Abrupt discontinuation after long-term use. A rebound syndrome of returning headache, anxiety, and muscle and joint stiffness is described Jahromi 2021. The practical implication is to taper rather than stop, which is not something most supplements require.

Oral ulceration from chewing the leaf is the classic adverse effect, is dose-related, and follows directly from parthenolide's reactivity with tissue thiols.

Asteraceae allergy is well characterized for this family and matters more here than for most herbs. Cross-reactivity with ragweed, chrysanthemum, daisy and arnica ranges from contact dermatitis to systemic reactions Klučevšek 2025, and sesquiterpene lactones are the specific sensitizers.

Avoid in pregnancy — emmenagogue and abortifacient effects are described in traditional use — and note that identity and content failures are common enough across commercial herbal products Ichim 2021 that a product's stated species is itself part of the risk.

Sources read for this page

How you would know if it worked

There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.

Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.

Feverfew — safety & side effects

Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.

🔒
The dose is the easy part. Making Feverfew actually work is what's behind Skool:
Running it
  • When to take it, and what to take it with
  • Which form actually absorbs
  • Who it's worth it for
  • Coach Cam's stacks and notes
When to take it
  • Fasted or with food, and when in the day
  • Morning or night, and why that window
  • Around training, or deliberately away from it
  • What it must not share a window with

Everything above is free and stays free. Skool is where it becomes a plan — Feverfew in an order, with the rest of what you're running.

Unlock in Skool — $10/mo →

Bloodwork to run alongside Feverfew

Baseline first, then again at 8–12 weeks.

MarkerWhat it’s watching for
TSH (Thyroid-Stimulating Hormone)Thyroid disease imitates every cognitive complaint there is
Vitamin B12Deficiency causes fog long before it causes anemia
Methylmalonic Acid (MMA)Catches the deficiency a normal B12 hides
FerritinLow iron flattens cognition at levels most labs call fine
Vitamin D (25-Hydroxy)Commonly low, cheap to correct, associated with mood

The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.

Check results you already have → · All 103 markers A–Z

Feverfew — frequently asked questions

What is Feverfew?

A migraine herb sold on a marker molecule that may not be the active one. Labels standardize to parthenolide, a sesquiterpene lactone; a controlled trial of an alcoholic extract standardized to parthenolide failed, while the extract with the best trial result is a supercritical CO2 preparation with a different constituent profile. That is an awkward fact for a category whose entire quality claim is the parthenolide number.

What is the suggested dose of Feverfew?

Dried leaf products run 100–380 mg daily; extracts state a parthenolide percentage, commonly 0.2–0.7%. Prophylaxis is judged over months, not days. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.

Where can I find Feverfew dosing and the full breakdown?

The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.

Where can I buy Feverfew?

Coach Cam sources Feverfew from vetted, top-rated brands on iHerb — use the buy link on this page.

What Feverfew is used for

Feverfew appears under 1 goal in the goal router.

🧠 Focus, memory & cognitionNeuroinflammation & membrane integrity

Where this goes next

Go deeper$10/mo

The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.

← Browse the full Supplement Vault

↑ Back to on this page